Roth Capital Expects Weaker Earnings for Core Scientific

Core Scientific, Inc. (NASDAQ:CORZ) – Equities research analysts at Roth Capital reduced their Q2 2026 earnings per share estimates for shares of Core Scientific in a research report issued on Thursday, May 8th. Roth Capital analyst D. Aftahi now anticipates that the company will earn $0.01 per share for the quarter, down from their previous estimate of $0.02. The consensus estimate for Core Scientific’s current full-year earnings is $0.52 per share. Roth Capital also issued estimates for Core Scientific’s Q4 2026 earnings at $0.03 EPS, FY2026 earnings at $0.05 EPS, FY2027 earnings at $0.17 EPS and FY2028 earnings at $0.86 EPS.

A number of other equities analysts also recently commented on CORZ. Cantor Fitzgerald cut their price objective on shares of Core Scientific from $24.00 to $21.00 and set an “overweight” rating for the company in a research report on Thursday, February 27th. Keefe, Bruyette & Woods initiated coverage on shares of Core Scientific in a report on Monday, January 27th. They set an “outperform” rating and a $22.00 price target for the company. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $17.00 price objective on shares of Core Scientific in a report on Friday. Compass Point cut their target price on Core Scientific from $26.00 to $20.00 and set a “buy” rating for the company in a research note on Tuesday, February 25th. Finally, HC Wainwright reissued a “buy” rating and issued a $17.00 price target on shares of Core Scientific in a report on Tuesday, March 11th. Fifteen analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $19.07.

Core Scientific Trading Down 1.4 %

NASDAQ:CORZ opened at $9.32 on Friday. The stock’s 50 day simple moving average is $7.92 and its 200-day simple moving average is $12.09. Core Scientific has a 12-month low of $3.46 and a 12-month high of $18.63. The firm has a market cap of $2.75 billion, a P/E ratio of -1.72 and a beta of 6.66.

Core Scientific (NASDAQ:CORZ) last issued its quarterly earnings data on Wednesday, May 7th. The company reported ($0.10) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.12) by $0.02. The business had revenue of $79.53 million for the quarter, compared to analysts’ expectations of $92.04 million. The company’s revenue for the quarter was down 55.6% on a year-over-year basis. During the same period in the previous year, the business posted $0.78 earnings per share.

Institutional Investors Weigh In On Core Scientific

A number of large investors have recently added to or reduced their stakes in CORZ. Wealth Enhancement Advisory Services LLC grew its stake in shares of Core Scientific by 25.6% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 98,077 shares of the company’s stock valued at $1,378,000 after acquiring an additional 20,000 shares in the last quarter. JPMorgan Chase & Co. grew its stake in Core Scientific by 48.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 437,812 shares of the company’s stock valued at $5,192,000 after purchasing an additional 142,068 shares in the last quarter. FNY Investment Advisers LLC increased its holdings in Core Scientific by 35.8% during the 4th quarter. FNY Investment Advisers LLC now owns 190,747 shares of the company’s stock worth $2,679,000 after purchasing an additional 50,275 shares during the last quarter. KLP Kapitalforvaltning AS acquired a new position in shares of Core Scientific in the 4th quarter valued at approximately $527,000. Finally, Stephens Inc. AR purchased a new position in shares of Core Scientific during the 4th quarter valued at approximately $927,000.

Insider Buying and Selling at Core Scientific

In related news, Director Jordan Levy bought 62,500 shares of the company’s stock in a transaction that occurred on Thursday, March 6th. The shares were acquired at an average cost of $8.01 per share, for a total transaction of $500,625.00. Following the acquisition, the director now owns 306,887 shares in the company, valued at $2,458,164.87. This represents a 25.57 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Todd A. Becker sold 134,250 shares of the business’s stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $10.75, for a total value of $1,443,187.50. Following the transaction, the director now directly owns 195,687 shares in the company, valued at $2,103,635.25. This trade represents a 40.69 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.40% of the stock is currently owned by corporate insiders.

Core Scientific Company Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.